Extractable definition: "A non-live gut health ingredient acts on the gut microbiome without delivering live organisms, either by feeding the bacteria already present, by supplying cell material, or by modulating what the resident community does."
The viability problem is a supply chain problem
Probiotics work. The constraint is not the biology, it is that the biology has to survive shipping and storage.
An organism that must be alive at the point of consumption sets your terms for you:
- Cold chain or coating. Either the supply chain gets refrigerated, or the strain gets protective encapsulation that adds cost and mass.
- Overage. You formulate above the label count so the product still meets it at end of shelf life. You pay for organisms the consumer never counts.
- A shelf-life claim tied to a count. Stability testing measures CFU decay, and the claim expires with it.
- Format limits. Heat, moisture, and water activity are all hostile. That constrains bars, gummies, RTD beverages, and anything baked or pasteurised.
- Co-formulation limits. Some acids, minerals, and botanicals reduce viability, so the rest of the formula has to work around the organism.
None of this makes probiotics a bad choice. It makes them an expensive one in formats where viability is hard to hold.
The three non-live routes
They are genuinely different mechanisms, and they buy different things.
| Route | What it delivers | Typical intake | Claim ceiling today |
|---|---|---|---|
| Feed what is there (prebiotic substrates) | Fermentable material for resident bacteria | Gram-scale for conventional fibre; less for purified fractions | Gut health, well established |
| Supply cell material (postbiotics) | Heat-killed cells, cell fractions, metabolites | Highly variable, from a few mg upward | Gut health, varies by preparation |
| Modulate what is there (precision bioactives) | A molecule that changes what resident species do | Milligram-scale | Gut health, with adjacent axes under study |
All three are shelf-stable in principle, because none of them has anything alive to keep alive.
What you gain, and what you still have to earn
Gain. No cold chain and no protective coating. No overage arithmetic. Stability testing measures a molecule. Formats open back up, including heat-processed and ambient ones. The specification becomes chemistry, which is easier to control batch to batch than a living count.
Earn. Probiotic claims are strain-specific, tied to named organisms. A non-live route carries its own evidence, on its own endpoints, at its own dose. Ask any supplier to show you which evidence is theirs and at what stage.
How to specify a non-live gut ingredient
Five questions. They apply to us as much as to anyone.
1. What is the active, and how is it standardised? A defined marker with a stated tolerance is what makes batches comparable. Ask what the assay is. 2. What is on the certificate of analysis? Identity, purity, contaminants, and the active's own specification. 3. Does it need protecting in-format? Ask about pH, heat, and moisture. 4. At what dose was the effect measured, and in what model? Ex-vivo, animal, and human data are three different arguments. A supplier should label which one they have. 5. What can go on pack today? Present claims and future claims are separate conversations. Ask for both, separately.
Where Trilliome sits
Neither of our actives contains live cells.
TRI-01 modulates. A shelf-stable, plant-derived small molecule that selectively induces a named four-species consortium of keystone gut bacteria, at a milligram-scale daily dose, in any format. There is no viability requirement and no cold chain. The induction data is from ex-vivo human gut models. Gut-health claims at launch, with gut-brain as the evidence builds.
TRI-04 feeds. A low-molecular-weight, water-soluble prebiotic fibre that supports the gut's butyrate-producing bacteria, without the gram-scale bulk that keeps conventional fibre out of compact formats. A metabolic-health claim path via the GLP-1 axis is under study.
Both are produced by green, food-grade extraction from upcycled agricultural side-streams, and both ship and store without a cold chain.
Request specs & samples → Quality & manufacturing → Low-dose actives →
FAQ
- What is a non-probiotic gut health ingredient? One that acts on the gut microbiome without delivering live organisms. It either feeds the bacteria already present, supplies cell material, or modulates what the resident community does.
- Do non-live gut ingredients need refrigeration? Generally no. Refrigeration and protective coating exist to keep organisms alive. An ingredient with nothing alive in it has no viability to protect.
- Are postbiotics the only alternative to probiotics? No. Postbiotics supply cell material. Prebiotic substrates feed resident bacteria, and precision bioactives modulate what those bacteria do. Three different mechanisms.
- Can a non-live ingredient change the microbiome? Yes. Feeding resident bacteria changes which ones thrive, and modulating them changes what they produce. Neither requires adding organisms.
- Why do probiotics need overage? Because the label states a count at end of shelf life, and populations decline in storage. Formulating above the label is how the count is still met on the last day.
- Which formats are hard for live probiotics? Anything with heat, moisture, or free water. Bars, gummies, RTD beverages, and heat-processed foods are the usual problem cases.
- Is a non-live ingredient easier to formulate with? Usually, because the specification is chemical. It still has to be assessed for pH, heat, and moisture sensitivity in your format.